144 related articles for article (PubMed ID: 28258040)
1. Angiomodulators in cancer therapy: New perspectives.
Varinska L; Kubatka P; Mojzis J; Zulli A; Gazdikova K; Zubor P; Büsselberg D; Caprnda M; Opatrilova R; Gasparova I; Klabusay M; Pec M; Fibach E; Adamek M; Kruzliak P
Biomed Pharmacother; 2017 May; 89():578-590. PubMed ID: 28258040
[TBL] [Abstract][Full Text] [Related]
2. Anti-Angiogenetic Agents from the Sea: A New Potential Preventive and Therapeutic Wave?
Gammone MA; Danese A; D'Orazio N
Anticancer Agents Med Chem; 2020; 20(17):2005-2011. PubMed ID: 32628594
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic effects of marine sponge derived compounds on cancer.
Senthilkumar K; Venkatesan J; Manivasagan P; Kim SK
Environ Toxicol Pharmacol; 2013 Nov; 36(3):1097-108. PubMed ID: 24148290
[TBL] [Abstract][Full Text] [Related]
4. Search for Anti-angiogenic Substances from Natural Sources.
Kotoku N; Arai M; Kobayashi M
Chem Pharm Bull (Tokyo); 2016; 64(2):128-34. PubMed ID: 26833441
[TBL] [Abstract][Full Text] [Related]
5. Natural Products with Antiangiogenic and Antivasculogenic Mimicry Activity.
Guan YY; Luan X; Lu Q; Liu YR; Sun P; Zhao M; Chen HZ; Fang C
Mini Rev Med Chem; 2016; 16(16):1290-1302. PubMed ID: 26864555
[TBL] [Abstract][Full Text] [Related]
6. Marine-derived angiogenesis inhibitors for cancer therapy.
Wang YQ; Miao ZH
Mar Drugs; 2013 Mar; 11(3):903-33. PubMed ID: 23502698
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
Ebrahim HY; El Sayed KA
Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26978377
[TBL] [Abstract][Full Text] [Related]
8. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions.
Lin Z; Zhang Q; Luo W
Eur J Pharmacol; 2016 Dec; 793():76-81. PubMed ID: 27840192
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic agents in natural products for the treatment of gynecologic disorders.
Aghamohammadi A; Hosseinimehr SJ
Nutr Cancer; 2014; 66(2):206-13. PubMed ID: 24410431
[TBL] [Abstract][Full Text] [Related]
11. Unraveling galectin-1 as a novel therapeutic target for cancer.
Astorgues-Xerri L; Riveiro ME; Tijeras-Raballand A; Serova M; Neuzillet C; Albert S; Raymond E; Faivre S
Cancer Treat Rev; 2014 Mar; 40(2):307-19. PubMed ID: 23953240
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic alternatives to VEGF blockade.
Khan KA; Bicknell R
Clin Exp Metastasis; 2016 Feb; 33(2):197-210. PubMed ID: 26620208
[TBL] [Abstract][Full Text] [Related]
13. Cancer Phytotherapy: Recent Views on the Role of Antioxidant and Angiogenesis Activities.
Bahmani M; Shirzad H; Shahinfard N; Sheivandi L; Rafieian-Kopaei M
J Evid Based Complementary Altern Med; 2017 Apr; 22(2):299-309. PubMed ID: 26753686
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic drugs: current knowledge and new approaches to cancer therapy.
Mauriz JL; González-Gallego J
J Pharm Sci; 2008 Oct; 97(10):4129-54. PubMed ID: 18200520
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of anti-angiogenic therapy in ovarian cancer (review).
Conteduca V; Kopf B; Burgio SL; Bianchi E; Amadori D; De Giorgi U
Int J Oncol; 2014 May; 44(5):1417-24. PubMed ID: 24626312
[TBL] [Abstract][Full Text] [Related]
16. Galectins in tumor angiogenesis.
Griffioen AW; Thijssen VL
Ann Transl Med; 2014 Sep; 2(9):90. PubMed ID: 25405165
[TBL] [Abstract][Full Text] [Related]
17. Isoxanthohumol modulates angiogenesis and inflammation via vascular endothelial growth factor receptor, tumor necrosis factor alpha and nuclear factor kappa B pathways.
Negrão R; Duarte D; Costa R; Soares R
Biofactors; 2013; 39(6):608-22. PubMed ID: 23904052
[TBL] [Abstract][Full Text] [Related]
18. Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Wilson PM; LaBonte MJ; Lenz HJ
Cancer Chemother Pharmacol; 2013 Jan; 71(1):1-12. PubMed ID: 23053262
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitors of neoangiogenesis in antineoplastic therapy].
Opolski A; Wietrzyk J
Postepy Hig Med Dosw; 2001; 55(3):369-85. PubMed ID: 11505638
[TBL] [Abstract][Full Text] [Related]
20. Galectins in the tumor endothelium: opportunities for combined cancer therapy.
Thijssen VL; Poirier F; Baum LG; Griffioen AW
Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
